First line treatment of advanced non-small-cell lung cancer – specific focus on albumin bound paclitaxel

Lung cancer is the leading cause of cancer mortality worldwide in both men and women. Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for more than 80% of cases. Paclitaxel has a broad spectrum of activity against various malignancies, including NSCLC. Paclitaxe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Neha, Hatoum, Hassan, Dy, Grace K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875520/
https://www.ncbi.nlm.nih.gov/pubmed/24399877
http://dx.doi.org/10.2147/IJN.S41770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875520/
https://www.ncbi.nlm.nih.gov/pubmed/24399877
http://dx.doi.org/10.2147/IJN.S41770

Ejemplares similares